2-aryl-propionamide derivatives useful as bradykinin receptor antagonists and pharmaceutical compositions containing them
EP2308485A1
Sulfonamides for the prevention of diabetes
EP2308484A1
Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets
EP2166006A1
2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them
BRPI0814716A2
Efervescent pills for inhalation
WO2006063999A1
2-arylpropionic acid derivatives and pharmaceutical compositions containing them
EP1621550A1
Tumor-homing cells engineered to produce tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
MXPA06000017A
Pharmaceutical combination of g-csf and plgf useful for blood stem cell.
CN1732145A
Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases
AU2003274060A1
Painless injectable compositions containing salt of 2-arylpropionic acids
EP1457485A1
Sulfonic acids, their derivatives and pharmaceutical compositions containing them
EP1454636A1
Sterilization of glucocorticoid drug particles for pulmonary delivery
EP1440082A1
Supercritical fluids processing: preparation of protein microparticles and their stabilisation
IL157560D0
Omega aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
UA73790C2
2,2-disubstituted 1,3-dioxolanes, a method for the preparation and use as intermediary products for the synthesis of respective (s)- enantiomers and (-)3-(4-phenyl-1-piperazinyl)-1,2-propanediol
CA2420585A1
Amides of r-2-(aminoaryl)-propionic acids for use in the prevention of leucocyte activation
